Drugmakers struggle for survival

Fierce competition in domestic ethical market is making it harder for companies to do business.

As the massive drug price cut plan is expected to take effect in April, analysts expect a large number of mergers and acquisitions (M&As) to take place among companies, and restructuring seems inevitable to offset worsening profitability.

They say the problem is that there are too many players ...